Weiwei Zhang
- Cancer Research top 10%
- MicroRNA in disease regulation 11
- Cancer-related molecular mechanisms research 5
-
- Circular RNAs in diseases 9
- Plant Gene Expression Analysis 6
- RNA Interference and Gene Delivery 5
- Enzyme Catalysis and Immobilization 5
- Advanced biosensing and bioanalysis techniques 5
-
- Cancer-related Molecular Pathways 5
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Weiwei Zhang
56 papers receiving 975 citations
Peers
Comparison fields: 5 of 109
- Cancer Research 251
- Molecular Biology 691
- Biochemistry 37
- Immunology 83
- Oncology 107
Countries citing papers authored by Weiwei Zhang
This map shows the geographic impact of Weiwei Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Zhang more than expected).
Fields of papers citing papers by Weiwei Zhang
This network shows the impact of papers produced by Weiwei Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Zhang. The network helps show where Weiwei Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weiwei Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 11 | |
| 6 | 2023 | 5 | |
| 7 | 2022 | 9 | |
| 8 | 2022 | 7 | |
| 9 | 2021 | 37 | |
| 10 | 2021 | 12 | |
| 11 | 2021 | 6 | |
| 12 | 2021 | 16 | |
| 13 | 2020 | 21 | |
| 14 | 2020 | 7 | |
| 15 | 2019 | 19 | |
| 16 | 2018 | 14 | |
| 17 | 2016 | 7 | |
| 18 | 2016 | 49 | |
| 19 | Isolation and characterization of a phenylalanine ammonia-lyase gene (PAL) promoter from Ginkgo biloba and its regulation of gene expression in transgenic tobacco plants. | 2014 | 7 |
| 20 | 2010 | 5 |
About Weiwei Zhang
Weiwei Zhang is a scholar working on Cancer Research, Molecular Biology and Aging, having authored 65 papers that have together received 981 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (11 papers), Circular RNAs in diseases (9 papers), Plant Gene Expression Analysis (6 papers), RNA Interference and Gene Delivery (5 papers), Enzyme Catalysis and Immobilization (5 papers), Cancer-related molecular mechanisms research (5 papers), Cancer-related Molecular Pathways (5 papers) and Advanced biosensing and bioanalysis techniques (5 papers). The work is most often cited by research in Cancer Research (251 citations), Molecular Biology (691 citations) and Biochemistry (37 citations). Weiwei Zhang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Ming Zheng, Shuo Ma, Yanhua Xu, Mei Tao, Feng Xu, Anmei Deng, Tengda Li, Yun Liu, Guo Jie and Mingli Gu. Their work appears in journals such as Nature Communications, PLoS ONE and Analytical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.